Cervarix is recommended for females aged 9 to 25, but it is most effective when administered before exposure to HPV, typically before the onset of sexual activity. The Centers for Disease Control and Prevention (CDC) suggest routine vaccination for preteens at ages 11-12, although catch-up vaccinations are recommended up to age 26.
